← Back
Data updated: Mar 10, 2026
CUBIST PHARMS LLC
Infectious DiseaseDermatology
CUBIST PHARMS LLC is a specialty pharmaceutical company focused on Infectious Disease, Dermatology. Key products include ZERBAXA.
2003
Since
6
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
Recent Activity
CUBICIN 2025-05-12
Labeling
CUBICIN 2025-05-08
Labeling
SIVEXTRO 2025-04-04
Efficacy
SIVEXTRO 2025-04-04
Efficacy
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 67%
2 drugs
Dermatology 33%
1 drugs
Pipeline Strength Pro
Loading...